Gut Microbiome Reduces Brain’s Interest in Alcohol
The gut microbiome has been increasingly connected to a myriad of conditions, in part due to the metabolic output of the microbes in the gut. Studies have suggested that exposure…
The gut microbiome has been increasingly connected to a myriad of conditions, in part due to the metabolic output of the microbes in the gut. Studies have suggested that exposure…
Credit: nopparit / iStock / Getty Images Plus For decades, neuroscientists have debated whether synaptic vesicles “kiss-and-run” or do an irreversible “full collapse” when releasing neurotransmitters. Now, a team in…
The sensing principle of these sensors is straightforward: the molecular target or drug to be monitored (shown in green in the illustration above) can interact with a specific DNA molecule,…
New research led by scientists from the RIKEN Center for Brain Science points to astrocytes as the brain cells responsible for long-term learning and memory. In a new Nature paper,…
Scientists based in New York have developed a new technique for removing impurities from mRNA therapies. The researchers, from the Rensselaer Polytechnic Institute (RPI), found that their regenerated cellulose (RC)…
Planarian flatworms pictured in the Stowers Institute’s planarian facility. A recent discovery from Stowers scientists may help explain the flatworm’s extraordinary ability to regenerate—and could offer clues for developing new…
With its pipeline expanding beyond its initial focus on in vivo programming of myeloid cells, for which the company took its initial name, Myeloid Therapeutics has rebranded as Create Medicines…
Credit: Steve Gschmeissner/Science Photo Library/Getty Images An international study led by scientists at Flinders University and at South China University of Technology has uncovered a new vulnerability in prostate cancer…
KPMG recently released its 2025 U.S. CEO Outlook. A critical section of the survey, which took place in September, explored the views of over 100 life sciences CEOs to assess…
If developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) were a poker game, you could say Novo Nordisk (NASDAQ Copenhagen: NOVO-B) saw a competitor’s bet and raised the stakes with its…